語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
到查詢結果
[ subject:"Epidemiology." ]
切換:
標籤
|
MARC模式
|
ISBD
Relationship between Quality of Life...
~
Ford-Scheimer, Stephanie L.
FindBook
Google Book
Amazon
博客來
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers./
作者:
Ford-Scheimer, Stephanie L.
出版者:
Ann Arbor : ProQuest Dissertations & Theses, : 2017,
面頁冊數:
123 p.
附註:
Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.
Contained By:
Dissertation Abstracts International78-06B(E).
標題:
Epidemiology. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10256285
ISBN:
9781369552393
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
Ford-Scheimer, Stephanie L.
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
- Ann Arbor : ProQuest Dissertations & Theses, 2017 - 123 p.
Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.
Thesis (Ph.D.)--Walden University, 2017.
Research in the field of neuroendocrine tumors (NETs) has increased over the last decade, including studies focused on biochemical markers (biomarkers) of the disease. There is also growing interest in how NETs impact patients' quality of life (QOL). Consequently, there is a paucity of information about whether the expression of the specific disease biomarkers affects QOL as well as whether the primary tumor site impacts QOL. Using the explanatory model of health promotion and quality of life in chronic disabling conditions as the theoretical framework and data collected with the Norfolk QOL-NET instrument, this study's purpose was to fill that gap in knowledge through research questions addressing the relationship between the primary tumor site and NET patients' total QOL score as well as the effect of specific NET biomarkers on NET patients' total QOL score. Data were analyzed using descriptive statistics, one-way analysis of variance (ANOVA), regression analysis, and post hoc tests to determine significance. Results from an ANOVA showed that abnormal NET biomarkers affected total QOL (p = 0.011). In the analyses of whether the independent biomarker variables affected the dependent total QOL variable, only the result for Serotonin Normal was significant (p = 0.002). The presence of abnormal biomarker measurements also affected two of the Norfolk QOL-NET domains significantly, gastrointestinal and physical functioning (p = 0.005 and p = 0.030, respectively). By understanding the relationship between NETs and patient QOL, the potential positive social change implications are helping NET patients assess the severity of their condition, determining what affects their well-being, and using this information to help monitor their treatment/progress.
ISBN: 9781369552393Subjects--Topical Terms:
568544
Epidemiology.
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
LDR
:02715nmm a2200289 4500
001
2156530
005
20180517120323.5
008
190424s2017 ||||||||||||||||| ||eng d
020
$a
9781369552393
035
$a
(MiAaPQ)AAI10256285
035
$a
(MiAaPQ)waldenu:18521
035
$a
AAI10256285
040
$a
MiAaPQ
$c
MiAaPQ
100
1
$a
Ford-Scheimer, Stephanie L.
$3
3344289
245
1 0
$a
Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
260
1
$a
Ann Arbor :
$b
ProQuest Dissertations & Theses,
$c
2017
300
$a
123 p.
500
$a
Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.
500
$a
Adviser: Diana Naser.
502
$a
Thesis (Ph.D.)--Walden University, 2017.
520
$a
Research in the field of neuroendocrine tumors (NETs) has increased over the last decade, including studies focused on biochemical markers (biomarkers) of the disease. There is also growing interest in how NETs impact patients' quality of life (QOL). Consequently, there is a paucity of information about whether the expression of the specific disease biomarkers affects QOL as well as whether the primary tumor site impacts QOL. Using the explanatory model of health promotion and quality of life in chronic disabling conditions as the theoretical framework and data collected with the Norfolk QOL-NET instrument, this study's purpose was to fill that gap in knowledge through research questions addressing the relationship between the primary tumor site and NET patients' total QOL score as well as the effect of specific NET biomarkers on NET patients' total QOL score. Data were analyzed using descriptive statistics, one-way analysis of variance (ANOVA), regression analysis, and post hoc tests to determine significance. Results from an ANOVA showed that abnormal NET biomarkers affected total QOL (p = 0.011). In the analyses of whether the independent biomarker variables affected the dependent total QOL variable, only the result for Serotonin Normal was significant (p = 0.002). The presence of abnormal biomarker measurements also affected two of the Norfolk QOL-NET domains significantly, gastrointestinal and physical functioning (p = 0.005 and p = 0.030, respectively). By understanding the relationship between NETs and patient QOL, the potential positive social change implications are helping NET patients assess the severity of their condition, determining what affects their well-being, and using this information to help monitor their treatment/progress.
590
$a
School code: 0543.
650
4
$a
Epidemiology.
$3
568544
690
$a
0766
710
2
$a
Walden University.
$b
Public Health.
$3
1023863
773
0
$t
Dissertation Abstracts International
$g
78-06B(E).
790
$a
0543
791
$a
Ph.D.
792
$a
2017
793
$a
English
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10256285
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9356077
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入